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In Streptococcus iniae, lactate metabolism is dependent upon two proteins, lactate permease that mediates
uptake and lactate oxidase, a flavin mononucleotide-dependent enzyme that catalyzes oxidation of -hydroxy-
acids. A novel variant of the lactate oxidase gene, lctO, in Australian isolates of S. iniae from diseased
barramundi was found during a diagnostic screen using LOX-1 and LOX-2 primers, yielding amplicons of 920
bp instead of the expected 869 bp. Sequencing of the novel gene variant (type 2) revealed a 51-nucleotide
insertion in lctO, resulting in a 17-amino-acid repeat in the gene product, and three-dimensional modeling
indicated formation of an extra loop in the monomeric protein structure. The activities of the lactate oxidase
enzyme variants expressed in Escherichia coli were examined, indicating that the higher-molecular-weight type
2 enzyme exhibited higher activity. Growth rates of S. iniae expressing the novel type 2 enzyme were not reduced
at lactate concentrations of 0.3% and 0.5%, whereas a strain expressing the type 1 enzyme exhibited reduced
growth rates at these lactate concentrations. During a retrospective screen of 105 isolates of S. iniae from
Australia, the United States, Canada, Israel, Re´union Island, and Thailand, the type 2 variant arose only in
isolates from a single marine farm with unusually high tidal flow in the Northern Territory, Australia. Elevated
plasma lactate levels in the fish, resulting from the effort of swimming in tidal flows of up to 3 knots, may exert
sufficient selective pressure to maintain the novel, high-molecular-weight enzyme variant.
Streptococcus iniae is a major pathogen of farmed fish, re-
sulting in severe economic losses globally estimated at U.S.
$150 million annually (27). S. iniae is essentially a blood patho-
gen, with infection resulting in a generalized septicemia and
meningitis (1). During infection the pathogen avoids phagocy-
tosis by means of an antiopsonic capsule (4, 18, 22) and by
binding host serum components including immunoglobulins
(3) and fibrinogen (2). Little is known, however, about the
metabolism of S. iniae during infection although lactic acid
bacteria may produce L-lactate from fermentation of glucose.
In S. iniae a lactate oxidase gene, lctO, has been characterized
previously (11). The product of the lctO gene in S. iniae is a
flavin enzyme (L-lactate 2-monooxygenase, EC 1.13.12.4),
which catalyzes the oxidation of lactate to pyruvate, coupled
with reduction of O2 to H2O2 (11). Lactate oxidase has been
extensively characterized, both structurally and functionally, in
the cold-water marine pathogen Aerococcus viridans (9, 30, 35,
36); thus, the catalytic activities of these enzymes are relatively
well understood. In S. iniae, lactate can be utilized as an energy
source through an aerobic but nonrespiratory mode of metab-
olism (11), a mechanism that is coupled to hydrogen peroxide
production in Streptococcus pyogenes (26).
Since the discovery of the lactate oxidase gene in S. iniae, its
presence has been routinely used for PCR-based diagnosis,
overcoming the lack of specificity of commercial biochemical
diagnostic kits and other molecular methods. Confirmation of
isolate identity as S. iniae by commercial bacterial identifica-
tion kits is problematic because the biochemical profile is ab-
sent from databases supplied with the kits or because the
databases are unable to identify atypical strains with confi-
dence (25). Identification of isolates by molecular methods
such as PCR is more reliable since isolates with atypical bio-
chemical profiles can confidently be identified. PCR has been
used to amplify sections of the 16S rRNA gene (37), the chap-
eronin HSP60 (12), and the 16S-23S rRNA gene intergenic
spacer region (5) for identification of S. iniae. The develop-
ment of the lactate oxidase gene (lctO) PCR assay by Mata et
al. (21) reported that the primer pair LOX-1/LOX-2 could be
used successfully to aid in the identification of S. iniae via the
generation of a specific 870-bp product. Moreover, the LOX-
1/LOX-2 primer pair overcame the problem of nonspecific
amplification of Streptococcus difficilis that had previously been
reported with the 16S rRNA gene primer pair described pre-
viously (21, 37).
In Australia, S. iniae causes major economic loss in farmed
barramundi (Lates calcarifer, Bloch) (1, 6). Barramundi, also
known as Asian sea bass, are perciform euryhaline fish native
to Australia and tropical southeast Asia. In Australia, bar-
ramundi have both cultural and commercial significance in
terms of their iconic status among indigenous populations and
the recent rapid growth of commercial farming. The value of
intensive barramundi culture in Australia increased from Aus-
tralian $15.5 million in 2004 to Australian $23.5 million in 2006
(34). There is also increasing farmed output of L. calcarifer in
Malaysia, Indonesia, Taiwan, and Vietnam (33) and small to
medium recirculating aquaculture ventures in the United
States and United Kingdom using imported fingerlings.
During routine diagnostic screening of S. iniae isolated
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throughout Australia from diseased barramundi, a novel vari-
ant of the lctO gene was found that resulted in amplicons of
920 bp following PCR using the LOX-1/LOX-2 primer pair.
Isolates expressing the novel lactate oxidase gene were isolated
only from a single site in the Northern Territory, Australia. In
the present study, the novel lctO variant is investigated genet-
ically and phenotypically in order to better understand how the
larger gene product may have arisen from this single site.
MATERIALS AND METHODS
Bacterial strains and culturing. S. iniae isolates from diseased barramundi
were obtained from veterinary laboratories throughout Australia; reference iso-
lates from the United States and Canada were obtained from Lynn Shewmaker
at the Centers for Disease Control and Prevention, Atlanta, GA; isolates from
Thailand, Israel, and Re´union Island were kindly provided by Christian Michel
of L’Institut National de la Recherche Agronomique, France (Table 1). Isolates
were stored in vegetable peptone broth (Oxoid, Thebarton, Australia) containing
20% glycerol at 80°C and routinely cultured on Columbia agar base containing
5% defibrinated sheep blood at 28°C for 24 h.
PCR amplification of the S. iniae lactate oxidase genes. Initially, the LOX-1/
LOX-2 primer pair was employed to amplify the lctO gene as confirmatory
diagnostic support for strains that had previously been identified as S. iniae based
on biochemical tests and clinical history by the supplying veterinary laboratories.
S. iniae genomic DNA was extracted from freshly grown cells using an enzymatic
lysis method (24). PCR of the lactate oxidase gene was performed as described
previously (21), and PCR amplification of the 16S rRNA gene with primers 27F
and 1492R was also performed as described previously (15). PCR amplification
of the full-length lctO gene was performed with primers LCTO22F and
LCTO1195R designed from the lctO sequence (accession number Y07622) (Ta-
ble 2). Cycling parameters included an initial denaturation step of 3 min at 94°C
followed by 35 cycles at 94°C for 15 s, 58°C for 1 min, and 72°C for 2 min, with
a final extension cycle at 72°C for 7 min. The resultant PCR products were
visualized in a 1% (wt/vol) agarose gel stained with ethidium bromide. Purified
full-length PCR products were ligated into pGEM-T (Promega, Sydney, Austra-
lia) and transformed into TOP10 cells (Invitrogen, Melbourne, Australia). Se-
quencing of the full-length lctO genes from clones was facilitated by primers
M13F, M13R, LCTO22F, LOX-1, LOX-2, and LCTO1195R (Table 2). The
lactate permease gene was amplified with LCTP F1 and LCTP R primers (Table
2) under similar cycling conditions, except that the annealing temperature was
56.3°C. Partial 16S rRNA gene sequences were obtained by sequencing PCR
products amplified using the universal 27F and 1492R bacterial 16S rRNA gene
primers with the 530F primer (Table 2).
Construction of recombinant lctO variants from S. iniae and expression in
Escherichia coli. The complete lactate oxidase genes from two strains represen-
tative of the two different lctO genes, QMA0165 (type 1) and QMA0177 (type 2),
were amplified using primers ELCTO 22F and ELCTOEK R (Table 2).
Genomic DNA (50 ng) from S. iniae strains in 25-l reaction mixtures containing
5 l of 5 PrimeSTAR buffer (Takara, Shiga, Japan), 0.2 mM deoxynucleoside
triphosphate mixture, 200 ng of forward and reverse primers, and 0.5 units of
PrimeSTAR proofreading Taq polymerase (Takara, Shiga, Japan) was amplified
with a Mastercycler Gradient EP-S Thermocycler (Eppendorf, Hamburg, Ger-
many). DNA was denatured at 94°C for 10 min, followed by 35 cycles of dena-
turation at 94°C for 15s, annealing at 56.7°C for 1 min, and elongation at 72°C for
2 min, with a final extension at 72°C for 10 min. To determine the quality of the
PCR products, 3 l of each amplification product was loaded onto 1% agarose
gels, stained with 0.5 g/ml ethidium bromide, and separated by electrophoresis
at 80 V for 45 min. PCR products were purified using a commercial kit (iNtRON
Biotechnology, Korea) and ligated overnight at 4°C into a Champion pET Di-
rectional TOPO expression vector in accordance with the manufacturer’s instruc-
tions (Invitrogen, Melbourne, Australia).
Vector constructs were transformed into chemically competent E. coli BL21
Star and selected with ampicillin (100 g/ml) on LB agar. Clones were picked,
and the direction and frame of the insert were confirmed by sequencing. Expres-
sion of the recombinant protein was induced in BL21 Star cells with isopropyl-
-D-thiogalactopyranoside (IPTG). Cells were harvested by centrifugation at
10,000  g for 5 min and washed in double-distilled H2O. To determine when
optimal induction occurred, cells harvested at 1, 2, and 3 h postinduction were
resuspended in 60 l of nonreducing sample buffer (0.125 M Tris, 20% glycerol,
20 g/ml bromophenol blue, 4% sodium dodecyl sulfate [SDS]) and lysed by
vortexing with approximately 40 mg of glass beads (150 to 212 m; Sigma, Castle
Hill, Australia). Protein concentrations were determined using a NanoDrop
ND-1000 spectrophotometer (NanoDrop Technologies, Rockland, DE).
Assay of lactate oxidase enzyme activity. Lactate oxidase enzyme activity was
determined by a peroxidase-coupled spectrophotometric assay (20). Cell lysates
were prepared from recombinant E. coli grown overnight (37°C at 200 rpm) and
then induced with IPTG for 3 h. Lysates were prepared by centrifuging the
induced cultures at 3,200  g for 20 min at 4°C. Cells were washed with 10 mM
potassium phosphate buffer, pH 6.5, and stored at 20°C until use. Cells were
resuspended with the same buffer and treated with lysozyme (0.5 mg/g of cells)
(Sigma, Castle Hill, Australia) for 6 h at 4°C, followed by disruption of the cells
with 40 mg of glass beads in a MagnaLyser bead mill (Roche Diagnostics,
Melbourne, Australia) at 4,500 rpm for 90 s. Cell debris and beads were removed
by centrifugation at 10,000  g for 5 min, and the supernatants were retained for
further analysis. Protein concentrations of the lysates were determined using a
bicinchoninic acid protein assay kit (Pierce, Rockford, IL) with bovine serum
albumin as a standard. Expressed recombinant type 1 and type 2 lactate oxidases
were assayed. Lactate oxidase derived from Pediococcus sp. (Sigma, Castle Hill,
Australia) with a concentration range of 10, 5, 2, 1, 0.5, and 0.2 U/ml was used
as an internal standard for the assays.
Enzyme assays were initiated by adding samples at various dilutions into
enzyme diluent comprising 10 mM potassium phosphate (P5379; Sigma, Castle
Hill, Australia) with 0.01 mM flavin adenine nucleotide (F6625; Sigma, Castle
Hill, Australia) (pH 6.5 at 37°C), 0.02% 2,2-azinobis (3-ethylbenzthiazolinesul-
fonic acid) (ABTS Fluka 11557, Sigma, Castle Hill, Australia), 10 mM L-()-
lactate, and 0.5 U of horseradish peroxidase (Sigma, Castle Hill, Australia). The
assay mixture was incubated in a thermomixer (Eppendorf, Hamburg, Germany)
at 37°C at 300 rpm for 20 min. The reaction was stopped by adding 0.25% sodium
dodecyl benzene sulfonate (Sigma, Castle Hill, Australia). Enzyme activity was
determined by reading the absorbance at 405 nm using a BMG Fluostar Optima
reader (BMG Labtech, Melbourne, Australia). The absorbance was read versus
a reagent blank without enzyme. All the assays were performed in triplicate at
each concentration (pseudoreplicates to determine within assay error). One unit
of lactate oxidase activity was defined as 1 mol of H2O2 produced per min at
37°C and pH 6.5. All enzyme assay experiments were repeated at least three
times, and results were analyzed by one-way analysis of variance (ANOVA)
followed by Tukey’s multiple comparison posttest to determine whether test
results were significantly different from each other and from controls.
Densitometric quantification of the lactate oxidase protein in cell lysates.
Proteins from lysates prepared above were separated by electrophoresis in SDS-
polyacrylamide gel electrophoresis (PAGE) gels (resolving gel, 10% [wt/vol]
acrylamide; stacking gel, 5% [wt/vol] acrylamide), using a Hoeffer SE260 system
(GE Healthcare, North Ryde, Australia). The lysate sample was loaded at a
concentration of 40 g per lane. Gels were stained with Brilliant Blue R250
(Sigma, Castle Hill, Australia) for 45 min with gentle agitation before being
destained in 40% methanol–10% acetic acid until backgrounds were clear. The
percentage of the expressed lactate oxidase gene products in cell lysates was
determined by densitometric analysis of four replicate electrophoretic separa-
tions of the lysates using an ImageQuant 400 gel documentation system and
direct quantification of band intensity with ImageQuant TL, version 2005, anal-
ysis software (GE Healthcare, North Ryde, Australia).
MIC. MICs of lactate for S. iniae isolates expressing the different lactate
oxidase genes were determined by broth microdilution or agar dilution. Strains
expressing the type 1 enzyme were QMA0076, QMA0140, and QMA0165, while
strains expressing the type 2 enzyme were QMA0109, QMA0126, and
QMA0177. MICs were also determined using the two recombinant E. coli strains
expressing the different enzyme types. The lactate MIC was determined using the
following range of dilutions of potassium lactate: 0, 0.1, 0.2, 0.3, 0.5, 1.0, 1.5, 2.0,
2.5, 3.0, 4.0, and 5.0%. The MIC using LB broth was determined in 96-well
plates. Inocula (10 l) of an overnight culture of S. iniae or recombinant E. coli
with an optical density at 600 nm of 0.2 were inoculated into 200 l of LB broth.
LB broth without lactate was inoculated with each of the strains as a positive
control while a negative control was left uninoculated. Absorbance at 600 nm was
read after incubation at 37°C overnight using a BMG Fluostar Optima reader.
For determination of the MIC using LB agar (Sigma, Castle Hill, Australia),
aliquots (10 l) of an overnight culture of S. iniae or recombinant E. coli at an
optical density at 600 nm of 0.2 were spotted onto surface-dried LB agar plates
containing lactate at the concentrations described above. Plates were incubated
at 37°C overnight, and the MIC was defined as the lowest concentration (per-
centage) of lactate that completely inhibited the growth of the bacteria.
Effect of lactate on growth rates of S. iniae. Growth rate experiments were
conducted in 100 l of LB broth containing potassium lactate concentrations of
0.1%, 0.3%, or 0.5% or without lactate. Standard inocula were prepared by
suspending overnight LB agar cultures of S. iniae QMA0165 (type 1 enzyme) or
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TABLE 1. S. iniae isolates used in this study
Strain Previousdesignation Host
a Year Siteb lctO genetype Geographic origin
QMA0070 95-40210 L. calcarifer 1995 Farm 1 1 Townsville, Queensland, Australia
QMA0071 0-43154 L. calcarifer 2000 Farm 2 1 Cairns, Queensland, Australia
QMA0072 95-40786 L. calcarifer 1995 Farm 1 1 Townsville, Queensland, Australia
QMA0073 98-43935 L. calcarifer 1998 Farm 3 1 Townsville, Queensland, Australia
QMA0074 98-51343 L. calcarifer 1998 Farm 3 1 Townsville, Queensland, Australia
QMA0075 98-47701 L. calcarifer 1998 Farm 3 1 Townsville, Queensland, Australia
QMA0076 98-49835 L. calcarifer 1998 Farm 3 1 Townsville, Queensland, Australia
QMA0077 95-47554 L. calcarifer 1995 Farm 1 1 Townsville, Queensland, Australia
QMA0078 1-41291 L. calcarifer 2001 Farm 2 1 Cairns, Queensland, Australia
QMA0079 1-43034 L. calcarifer 2001 Farm 2 1 Cairns, Queensland, Australia
QMA0080 AS-04-1503#7 L. calcarifer 2004 Farm 4 1 Lake Argyle, Western Australia, Australia
QMA0081 AS-04-1503#1 L. calcarifer 2004 Farm 4 1 Lake Argyle, Western Australia, Australia
QMA0082 AS-04-0018#1 L. calcarifer 2004 Farm 4 1 Lake Argyle, Western Australia, Australia
QMA0083 AS-04-0006#1 L. calcarifer 2004 Farm 5 1 S. Fremantle, Western Australia, Australia
QMA0084 AS-01-2199#1 Flying fox 2001 NA 1 Australia Quarantine and Inspection Service
QMA0087 Lake Argyle 1 L. calcarifer 2004 Farm 4 1 Lake Argyle, Western Australia, Australia
QMA0088 Lake Argyle 2 L. calcarifer 2004 Farm 4 1 Lake Argyle, Western Australia, Australia
QMA0109 05/0409 L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0110 05/0430-a L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0111 05/0430-g L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0112 05/0430-m L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0113 05/0580-c L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0114 05/0697-b L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0115 05/0748-a L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0116 05/0748-g L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0117 05/1082-gg L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0118 05/1151-c L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0119 05/1384-a L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0120 06/0064-b L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0121 06/0064-d L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0122 06/0064-e L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0123 06/0064-g L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0124 06/0064-h L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0125 06/0064-I L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0126 06/0064-j L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0127 06/0064-k L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0128 06/0064-l L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0129 06/0064-m L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0130 ss1440 H. sapiens 1 Canada
QMA0131 ss1543 H. sapiens 1 Canada
QMA0133 4780-01 H. sapiens 1 United States
QMA0134 4787-01 H. sapiens 1 United States
QMA0135 2388-02 H. sapiens 1 United States
QMA0136 1056-03 H. sapiens 1 United States
QMA0137 105-04 H. sapiens 1 United States
QMA0138 4989-04 H. sapiens 1 United States
QMA0139 2880-96 Fish (unknown sp.) 1 Canada
QMA0140 ss1056 I. geoffrensis 1 United States
QMA0141 ss1123 I. geoffrensis 1 United States
QMA0142 05/0430-D L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0143 05/0430-J L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0144 05/0972-A L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0145 05/0972-C L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0146 05/0972-D L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0147 05/1082-A L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0148 05/1151-A L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0149 05/1151-B L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0150 05/1151-D L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0151 05/1324-A L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0152 05/1324-B L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0153 05/1383-D L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0154 05/1385 L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0155 1 L. calcarifer 2006 Farm 7 1 New South Wales, Australia
QMA0156 2 L. calcarifer 2006 Farm 7 1 New South Wales, Australia
QMA0157 3 L. calcarifer 2006 Farm 7 1 New South Wales, Australia
QMA0158 4 L. calcarifer 2006 Farm 8 1 South Australia, Australia
Continued on following page
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QMA0177 (type 2 enzyme) in sterile phosphate-buffered saline (PBS) to an
optical density at 600 nm of 0.400 0.001. These two strains were initially chosen
as they were both isolated in the same year (2006) from diseased barramundi
farmed in commercial open marine water farms (Table 1). The strains were
received immediately by our laboratory from the respective veterinary laborato-
ries and placed into glycerol stock at 80°C with minimal further subculturing.
Microbroths were inoculated in 96-well plates with 10 l of the prepared inoc-
ulum and incubated at 28°C with gentle agitation. Growth was recorded hourly
by measurement of the optical density at 600 nm using a BMG Fluostar Optima
plate reader. Results from three independent experiments, performed simulta-
neously, were recorded. To determine whether the differences in growth could be
attributed to the different lactate oxidase enzymes, the experiment was repeated
with six additional strains of S. iniae, three expressing the type 1 enzyme
(QMA0088, QMA0218, and QMA0221) and three expressing the type 2 enzyme
(QMA0109, QMA0119, and QMA0126). The three strains expressing the type 1
enzyme were selected because they were isolated from geographically disparate
locations in different years (Table 1). As strains expressing the type 2 enzyme
were found only at one farm, the isolates were selected from separate outbreaks
of disease or by isolation on different occasions (Table 1). The experiment was
also repeated using the six strains above where either glucose or lactate was used
as the sole carbon source. A substrate utilization medium was prepared from
PBS containing calcium and magnesium (Thermo Scientific, Sydney, Australia)
with 0.1% NH4Cl added as a nitrogen source. This base diluent was then sup-
plemented with either 0.2% glucose or 0.2% lactate (as potassium lactate) as a
carbon source. The experiment was conducted in 100-l volumes precisely as
described above. Data were analyzed with GraphPad Prism, version 4, for Macin-
tosh (GraphPad Software, San Diego, CA; www.graphpad.com). First, growth
curves were fitted using the Gompertz equation for bacterial growth, and good-
ness of fit was determined. Data sets were compared by an F test to determine
TABLE 1—Continued
Strain Previousdesignation Host
a Year Siteb lctO genetype Geographic origin
QMA0159 5 L. calcarifer 2006 Farm 9 1 South Australia, Australia
QMA0160 6 L. calcarifer 1999 Farm 10 1 South Australia, Australia
QMA0161 7 L. calcarifer 2000 Farm 10 1 South Australia, Australia
QMA0162 8 L. calcarifer 2000 Farm 10 1 South Australia, Australia
QMA0163 9 L. calcarifer 2000 Farm 10 1 South Australia, Australia
QMA0164 06-40191 L. calcarifer 2006 Farm 11 1 Queensland, Australia
QMA0165 06-40593 L. calcarifer 2006 Farm 12 1 Queensland, Australia
QMA0166 06-40643 L. calcarifer 2006 Farm 12 1 Queensland, Australia
QMA0167 06-40925 L. calcarifer 2006 Farm 12 1 Queensland, Australia
QMA0168 06-40280 L. calcarifer 2006 Farm 11 1 Queensland, Australia
QMA0169 06-43862 L. calcarifer 2006 Farm 11 1 Queensland, Australia
QMA0170 06-43734 L. calcarifer 2006 Farm 12 1 Queensland, Australia
QMA0171 06-42715 L. calcarifer 2006 Farm 12 1 Queensland, Australia
QMA0173 AVM-2958 L. calcarifer Farm 10 1 South Australia, Australia
QMA0174 06/0784-A L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0175 06/0784-C L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0176 06/0784-E L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0177 06/0784-G L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0178 06/0784-I L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0179 06/0784-K L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0180 06/0784-M L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0181 06/0784-O L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0182 06/0784-Q L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0183 06/0784-S L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
QMA0184 UN3373 Fish (unknown sp.) 1
QMA0186 KFP404 O. mykiss 1 Israel
QMA0187 108-83(4) C. striata 1 Thailand (EUS)c
QMA0188 KFP173 O. mykiss 1 Israel
QMA0189 21-96(2) O. mykiss 1 Reunion Island
QMA0190 CII.5B-88 C. striata 1 Thailand (EUS)
QMA0216 E L. calcarifer 2007 Farm 11 1 Queensland, Australia
QMA0218 G L. calcarifer 2007 Farm 12 1 Queensland, Australia
QMA0219 H L. calcarifer 2007 Farm 12 1 Queensland, Australia
QMA0220 I L. calcarifer 2006 Farm 7 1 New South Wales, Australia
QMA0221 J L. calcarifer 2007 Farm 7 1 New South Wales, Australia
QMA0222 K L. calcarifer 2006 Farm 13 1 Victoria, Australia
QMA0227 P L. calcarifer 2005 Farm 6 2 Northern Territory, Australia
QMA0228 Q L. calcarifer 2006 Farm 6 2 Northern Territory, Australia
a H. sapiens, Homo sapiens; I. geoffrensis, Inia geoffrensis; O. mykiss, Oncorhynchus mykiss; C. striata, Channa stiata.
b NA, not applicable.
c EUS, epizootic ulcerative syndrome.
TABLE 2. PCR primers used in this study
Primer Sequence 5–3 Referenceor source
LOX-1 AAGGGGAAATCGCAAGTGCC 21
LOX-2 ATATCTGATTGGGCCGTCTAA 21
LCTO22Fa CAGGAAACAGCTATGAC This study
LCTO1195Ra GCATTAAAAAAACTGCCCTAA This study
LCTP F1 CATATGTTTCAAGCAATATTAGC This study
LCTP R CTACCTTCTTGACCTTCTAAA This study
M13F GTAAAACGACGGCCAG Invitrogen
M13R CAGGAAACAGCTATGAC Invitrogen
27F AGAGTTTGATCMTGGCTCAG 15
1492R TACGGYTACCTTGTTACGACTT 15
530F GTGCCAGCMGCCGCGG 15
a Numbering based on S. iniae lctO sequence (Y07622).
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whether growth curves at various lactate concentrations were different. Then
ANOVA was conducted to compare growth at each time point at the different
lactate concentrations. Analyses were repeated for each strain.
Sequence analysis and structural modeling of the lactate oxidase proteins.
The protein sequence of lactate oxidase in A. viridans (BAA09172), the predicted
protein sequence of the lactate oxidase previously described in S. iniae (accession
number Y07622), and the predicted protein sequences of the corrected type 1
lactate oxidase and the novel type 2 variant from S. iniae described in this paper
were aligned in Clustal X (28). Enzymatically active sites for A. viridans as
described in previous publications (10, 16, 17, 35, 36) that are conserved in S.
iniae were marked in the alignment. The Protein Data Bank (PDB) file of 2DU2
(30) on the resolved crystal structure of lactate oxidase in A. viridans was down-
loaded from the Research Collaboratory for Structural Bioinformatics PDB
(http://www.pdb.org/pdb/home/home.do) and subunits 2 and 3 were visualized
using PyMOL, version 1.0 (8). Protein models for type 1 and type 2 lactate
oxidases in S. iniae were predicted using the CPHmodels, version 2.0, server
(www.cbs.dtu.dk/services/) (19), where type 1 was modeled upon PDB entry
2J6X (16) and type 2 was modeled upon PDB entry 2DU2 (30). The protein
models were viewed in PyMOL, and two identical subunits were placed adjacent
to each other using Adobe Photoshop. Subunit interactions and predicted active
sites were as previously described for A. viridans (10, 16, 17, 35, 36).
Nucleotide sequence accession numbers. The predicted protein sequences of
the corrected type 1 lactate oxidase and the novel type 2 variant from S. iniae
described in this paper were deposited in the GenBank database under accession
numbers EU086697 and EU086704, respectively.
RESULTS
PCR amplification and sequencing of the lactate oxidase
and lactate permease from S. iniae. Two different sizes of PCR
product were obtained when the LOX-1/LOX-2 primer pair
was applied during screening of Australian S. iniae isolates.
Most strains gave an amplicon size of 869 bp while some of the
strains yielded amplicons of 920 bp (Fig. 1A). Strains produc-
ing an 869-bp product were designated as lctO type 1, and
those with the 920-bp product designated as lctO type 2 (Table
3). Sequencing and translation of the full-length lctO gene
showed that the 51-bp insertion was a repeat sequence (Fig. 2).
The first start codon rather than the next one in frame down-
stream was used as the start of the protein since there is some
ambiguity as to which codon is used.
In light of the size variations obtained for the lactate oxidase
gene from the putative S. iniae isolates, partial sequencing of
the 16S rRNA gene was performed with the 530F primer
(Table 2), and submission to the BLAST server (http://www
.ncbi.nlm.nih.gov/BLAST) returned identities of 100% to S.
iniae ATCC 29178. While absolute certainty of identity based
on high matches in the 16S rRNA sequence may not be guar-
anteed (13), the results taken in conjunction with the previous
biochemical identification by the veterinary laboratories con-
firm the identity of these isolates as S. iniae. No variation was
detected in the lactate permease gene lctP for any of the strains
analyzed (Fig. 1B).
A retrospective screen of all confirmed S. iniae isolates in
our collection indicated that the type 2 enzyme was restricted
to isolates from a single marine farm in the Northern Territory,
Australia (Table 1).
Lactate oxidase activity of recombinant lactate oxidases ex-
pressed in E. coli. To determine whether the variation in the
lactate oxidase sequence altered the enzyme activity, a series of
lactate oxidase enzyme activity assays was conducted on re-
combinant enzymes expressed in E. coli. Lactate oxidase was
assayed at a range of concentrations of cell lysate prepared
from the recombinant E. coli strains, and the results presented
in Table 3 are a representative set of the results from numer-
ous assays. To determine the specific activities of each enzyme
type, lysates from induced recombinant E. coli used in the
assays were separated by electrophoresis and stained with Coo-
massie brilliant blue R250 (Fig. 3). Gels were analyzed densi-
tometrically, and the amount of the induced enzyme band was
determined as a percentage of the total protein in 40 g of
lysate (Fig. 3 and Table 3). Lysates from E. coli expressing the
larger lctO type 2 had significantly higher (P  0.001, n 	 3)
lactate oxidase activity per mg of protein (17.86 units/mg) than
lysates from recombinant E. coli expressing lctO type 1 (14.47
FIG. 1. Amplicons of lactate oxidase type 1 and type 2 and lactate
permease from S. iniae. (A) Agarose gel (1%) separation of PCR
amplicons of the lactate oxidase gene lctO from Australian isolates of
S. iniae indicating different amplicon sizes with LOX primers (869 bp
and 920 bp, respectively). (B) Agarose gel (0.7%) separation of PCR
amplicons of the lactate permease gene lctP from Australian isolates of
S. iniae using the LCTP F1 and LCTP R primers. Lane M, Fermentas
Generuler molecular weight markers; lane 1, QMA0076; lane 2,
QMA0078; lane 3, QMA0080; lane 4, QMA0109; lane 5, QMA0126;
lane 6, QMA0140; lane 7, QMA0155; lane 8, QMA165; lane 9,
QMA0173; lane 10, QMA0177; lane 11, negative (template free) control.
TABLE 3. Lactate oxidase enzyme activities of extracts from E. coli expressing recombinant lctO type 1 or type 2
Organism lctO from cellextract
Activity
(U/mg of lysate  SD)a
Mean enzyme band
intensity (%)b
Specific activity
(U/mg enzyme)
E. coli BL21Star (DE3)/pET(lctOType1) Type 1 14.47  0.66 51.54  2.22 28.07
E. coli BL21Star (DE3)/pET(lctOType2) Type 2 17.86  0.43 39.03  1.40 45.76
a Activity of type 2 was significantly different from type 1 (P  0.001; n 	 3).
b Based on densitometric determination of enzyme band intensity in SDS-PAGE gels of IPTG-induced (3 h) recombinant cell lysates using ImageQuant software,
version 2005 (n 	 4).
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units/mg) (Table 3). When specific activity of the two enzymes
was calculated from the densitometric analysis, the difference
was more substantial as the type 2 enzyme was less efficiently
induced in the recombinant system and thus constituted a
lower proportion of the total protein in the lysate assayed (Fig.
3 and Table 3).
MIC of lactate against isolates expressing different lactate
oxidase enzymes. In order to ascertain whether the inserted
repeat in lctO type 2 and the associated change in enzyme
activity had any physiological significance, the MIC of lactate
was determined in LB broth and on LB agar. LB was chosen
over vegetable peptone or blood agar to minimize potential
inhibition of lactate oxidase enzyme expression in S. iniae iso-
lates by glucose in the medium. MICs of lactate using LB broth
as the medium were 1.5% for all strains assayed, regardless of
the lctO type expressed. When lactate MICs were determined
on LB agar, the MIC was higher at 2.5% to 3.0%. There were
no consistent differences in the lactate MIC for recombinant
strains expressing either the type 1 or type 2 enzyme or be-
tween S. iniae isolates QMA0165 and QMA0177.
Effect of lactate on growth rates of strains expressing the
different enzymes. As no differences were detected in the MICs
of lactate between the strains used, the effect of various lactate
concentrations on growth rate in LB broth was determined. A
nonlinear regression based on the Gompertz equation was
used to fit the curves to the growth data. Goodness of fit was
determined, and R2 values ranged between 0.9630 and 0.9797
for curves fitted to growth data for QMA0165 at the different
lactate concentrations and between 0.9369 and 0.9730 for
QMA0177. Having ascertained that curve fit was acceptable,
we performed an F test on the data sets for each of the isolates
to determine whether there were differences between the
growth curves at the different lactate concentrations, with the
null hypothesis in each case being that a single curve could fit
all the data sets for each strain. In the case of strain QMA0165
expressing the type 1 enzyme, the null hypothesis was rejected
(P 	 0.0096), indicating a significant effect of lactate concen-
tration on growth (Fig. 4A). In contrast, the F test on the data
sets for strain QMA0177, expressing the type 2 enzyme, did not
reject the null hypothesis (P 	 0.9735), indicating that a single
curve could fit all growth data regardless of lactate concentra-
tion (P 	 0.9735) (Fig. 4B).
The effect of lactate concentration on growth of each strain
over time was also analyzed by ANOVA. In agreement with
the nonlinear regression analyses and F test comparisons, no
significant effect of lactate concentration on growth over time
was detected in strain QMA0177 (P 	 0.7628) (Fig. 4B). How-
ever, growth of QMA0165 was significantly inhibited at lactate
concentrations of 0.3% and 0.5% compared to controls (P 	
0.0170) (Fig. 4A).
While assays of additional strains indicated that there was
some between-strain variation in the growth kinetics that could
not be attributed to the different enzymes (Fig. 5), the strains
expressing the type 2 enzyme were not in general adversely
affected by high concentrations of lactate in LB medium, and
growth seemed to be maximal with 0.3% lactate in these strains
FIG. 2. Nucleotide sequence differences in type 1 and type 2 lactate oxidase genes of S. iniae. The shaded gray boxes show differences between
the type 1 sequence (EU086702; this study), type 2 sequence (EU086704; this study), and the initial GenBank submission (Y07622) (11) in the
LOX-2 primer site and the misread C in the GenBank sequence. The unshaded boxes show the deduced stop codon for the two sequences. The
horizontal black bars show the primer sites for LOX-2 and LCTO1195R (which was used to amplify the complete gene).
FIG. 3. SDS-PAGE gels of IPTG-induced recombinant E. coli ly-
sates expressing type 1 and type 2 lactate oxidase enzymes. Lysate (40
g per lane) (lanes 2 to 5) from each of the recombinant isolates was
separated in SDS-PAGE gels (10% acrylamide resolving gel) under
reducing conditions. Molecular weight markers (Precision Plus; Bio-
Rad) were included on each gel (lane 1). Gels were scanned with an
Image Quant 400 system (GE Healthcare Biosciences) using transmit-
ted white light.
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(Fig. 5B, D, and F). In contrast, with the exception of strain
QMA0218 (which is highly mucoid), the strains expressing the
type 1 enzyme were generally inhibited by higher concentra-
tions of lactate (Fig. 5A, C, and E). For all strains except
QMA0218, growth curves at each lactate concentration were
significantly different from each other, and the null hypothesis
(the same curve for each lactate concentration) was rejected by
an F test.
Although LB broth does not contain glucose, it is a complex
medium containing many potential sources of carbohydrate.
Thus, the experiment was repeated a further time using the
same six strains. On this occasion, a basic substrate utilization
medium was prepared from commercially available PBS con-
taining calcium and magnesium to which ammonium chloride
was added as a source of nitrogen. This basic medium was then
supplemented with either lactate or glucose as carbon sources.
Growth was very low and slow in this medium for all strains,
and there was variation between strains (Fig. 6). Strains did not
grow as well in lactate as in glucose (Fig. 6), and this difference
was always statistically significant, regardless of the enzyme
type expressed. However, strains expressing type 1 enzyme
grew considerably less well with lactate instead of glucose as
carbon source than strains expressing the type 2 enzyme (Fig.
6). In strains QMA0088, QMA0218, and QMA0221, lactate
accounted for 10.30% (P  0.0001), 5.89% (P 	 0.0022), and
8.02% (P  0.0001) of the total variance, respectively, whereas
in strains QMA0109, QMA0119, and QMA0126, lactate ac-
counted for 2.32% (P 	 0.0002), 4.09% (P 	 0.0029), and
2.49% (P 	 0.0055) of the total variance, respectively.
Amino acid sequence and structure analysis. To elucidate
the potential structural alterations that may account for the
increased enzyme activity, the amino acid sequences derived
from the type 1 and type 2 lactate oxidase enzymes from S.
iniae were aligned and compared with a thoroughly character-
ized lactate oxidase from A. viridans (11, 29, 30). The align-
ment was used to predict a three-dimensional structural model
of the lactate oxidase monomer in PyMOL. Amino acid align-
ment of lactate oxidase in S. iniae from this study with a
previously described lactate oxidase (11) indicates some differ-
ences in the structure (Fig. 7); the previously described lactate
oxidase shows dissimilarities in three positions prior to the first
382 amino acids and major differences in the C-terminal re-
gion. Alignment of lactate oxidases from S. iniae and A. viri-
dans shows strongly conserved regions and indicates that the
majority of the amino acids involved in the active enzymatic
site of A. viridans are conserved in S. iniae (Fig. 7).
Predicted models of lactate oxidase in S. iniae both showed
very good fit to template models (E 	 1e104 for type 1 and
E 	 1e100 for type 2, respectively), indicating that our mod-
els are relatively robust. Comparisons of A. viridans lactate
oxidase and the two S. iniae lactate oxidases suggest that the
inserted sequence for type 2 lactate oxidase in S. iniae results
in an additional loop structure in close proximity to the active
site in the neighboring subunit of the lactate oxidase protein
complex (Fig. 8).
DISCUSSION
Cloning and sequencing the full-length lactate oxidase gene
from representative strains of S. iniae allowed two lctO types to
be identified on the basis of size. Apart from the insertion
sequence found in the 3 end of the gene in some isolates,
three nucleotides in positions 211 to 213, not previously de-
tected when the gene was described by Gibello et al. (11),
resulted in an inserted valine residue in the translated product
from all isolates. We note an apparent error in the primary
sequence and translation of the GenBank sequence (Y07622).
This is likely to be due to an inserted C nucleotide at position
FIG. 4. Influence of lactate on growth rates of similar marine strains of S. iniae in LB broth. Growth determined by optical density at 600 nm
(OD600) of QMA0165 expressing type 1 enzyme and QMA0177 expressing type 2 enzyme in LB broth containing 0, 0.1, 0.3, and 0.5% potassium
lactate. Data points indicate means, and error bars represent standard deviations from three independently inoculated cultures. Curves were fitted
using the Gompertz equation followed by an F test. The F test supported separate curves for growth data for QMA0165 (P 	 0.0096) but a single
curve for growth data for QMA0177 (P 	 0.9735).
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FIG. 5. Influence of lactate on growth rates of diverse S. iniae strains in LB broth. Growth determined by optical density at 600 nm (OD600)
of QMA0088 (type 1), QMA0109 (type 2), QMA0218 (type 1), QMA0119 (type 2), QMA0221 (type 1), and QMA0126 (type 2) in LB broth
containing 0, 0.1, 0.3, and 0.5% potassium lactate. Data points indicate means, and error bars represent standard deviations from three
independently inoculated cultures. Curves were fitted using the Gompertz equation followed by an F test.
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FIG. 6. Glucose and lactate utilization by diverse S. iniae strains expressing type 1 or type 2 lactate oxidase. Growth determined by optical density at
600 nm (OD600) of QMA0088 (type 1), QMA0109 (type 2), QMA0218 (type 1), QMA0119 (type 2), QMA0221 (type 1), and QMA0126 (type 2) in PBS
containing Ca2, Mg2, and NH4Cl supplemented with either 0.2% potassium lactate or 0.2% D-glucose. Data points indicate means, and error bars
represent standard deviations from three independently inoculated cultures. Curves were fitted using the Gompertz equation followed by an F test.
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1148 of the lctO gene at the far 3 end of the gene sequence
(inside the LOX-1/LOX-2 priming region) that has altered the
reading frame (11). This means that the expected PCR product
size of 870 bp is incorrect and is actually 869 bp. A factor that
has greater implications for the specificity of the diagnostic
PCR is the misinterpretation of the position of the stop codon
since the 3 end of the LOX-2 primer is located downstream of
the stop codon in all of the isolates that we sequenced. Vari-
ations in intergenic spacer regions are likely to produce results
that are slightly different from those expected. We also de-
tected a mismatch in the LOX-2 primer sequence with all of
the isolates presented here and suggest that the basis of the
design of the LOX-2 primer is flawed since the data used to
design the primer contained errors. The redesign of the LOX-2
primer or its replacement with a primer that is located in the
lctO gene itself should be considered although this may reduce
the specificity of the assay due to the conserved 3 end of the
lactate oxidase gene.
In Australian isolates the production of an amplicon of 869
bp is not the only result that can be obtained using the LOX-
1/LOX-2 primer set with S. iniae. While the method has been
tested for specificity (21), there needs to be awareness among
diagnosticians that amplicons that are of higher molecular
weight can be produced by atypical strains. These larger am-
plicons should not be disregarded and may be serendipitous
indicators that can be used in epidemiological studies of S.
iniae.
Type 1 lactate oxidase appears to be the dominant form of
LOX protein in S. iniae in the strain collection used in this
study. In total, 105 strains mainly from Australia, but also from
Israel, Re´union Island, Thailand, the United States, and Can-
ada were investigated. The type 1 lactate oxidase protein struc-
ture of S. iniae shares similarities with lactate oxidase proteins
described in other organisms such as that of A. viridans, and it
is interesting that the type 2 lactate oxidase in S. iniae was
detected only in strains derived from a single location in the
Northern Territory, Australia. Type 2 variants contain a repeat
insert of 17 additional amino acids that are predicted to form
an additional loop in close proximity to the active binding site
of a neighboring subunit in the enzyme complex. The lactate
FIG. 7. Alignments and comparisons of lactate oxidase proteins in S. iniae and A. viridans. Shading indicates homology (black, 100%; gray, 80%;
and light gray, 60%). Black dots below alignment denote conserved amino acids within monomers that participate in the enzymatically active site
of LOX in A. viridans. The gray dot below the alignment denotes a conserved amino acid suggested to be involved in the enzymatic active site on
a neighboring subunit. Accession numbers are as follows: S. iniae lctO type 1, EU086697; S. iniae lctO type 2, EU086704; S. iniae lactate oxidase
lctO Si, Y07622; A. viridans lactate oxidase, BAA09172.
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oxidase activity in type 2 is enzymatically more efficient than
that of type 1, leading us to speculate on the function of the
additional insert. The predicted structure suggests that the
additional loop may function in enhancing enzyme activity at
the binding site by improving capture of the substrate. The
existence of the extra loop changes conformation of the mul-
timeric lactate oxidase structure where, in addition to increas-
ing the enzyme efficiency, it may act to stabilize the enzyme.
The flip-flop action of the His265 in the lactate oxidase en-
zyme–D-lactate complex in A. viridans increases the space
within the active site of the lactate oxidase enzyme. Changes in
the conformational structure have also led to the formation of
a hydrogen-bonding network between the residues His265-
Asp174-Lys221. All these residues are very well conserved in
the 
-hydroxyoxidase family members (29). It has also been
suggested that the hydrogen bond network is important for the
enzymatic activity (10). Changes in the lactate oxidase struc-
ture have also been reported to broaden the active site of the
lactate oxidase enzyme (17). Binding of the active site to the
substrate may induce a conformational change, as reported
during substrate binding in the A. viridans lactate oxidase en-
zyme (10), which may involve the loop in efficient substrate
channeling to the active site. However, future crystallographic
studies on the interaction of the enzyme with the substrate will
be required to reveal the true function of the insert.
The questions of why and how this variant of the gene arose
at only one farm site and how a larger gene product has been
maintained remain to be answered. The increased activity of
the larger enzyme is indicative of a potential requirement for
improved lactate metabolism in that particular environment.
This is supported by the preliminary experiment investigating
the effect of lactate on the growth rate of the two strains
isolated in the same year under similar conditions (both from
barramundi in large commercial open seawater farms) but
expressing two different enzymes. Lactate concentrations of
0.3% and 0.5% significantly reduced the growth rate of the
strain containing the type 1 enzyme (QMA0165) while there
was no significant effect on growth rate of the strain containing
the type 2 enzyme (QMA0177). Further investigation using
multiple strains indicated there was significant strain-to-strain
variability among growth rates in the presence or absence of
lactate that could not be accounted for by enzyme type, but
there was a trend for strains expressing type 2 enzyme to be
less adversely affected by high concentrations of lactate than
those expressing the type 1 variant. Clearly, carbohydrate me-
tabolism in bacteria is highly complex and will be affected by
multiple factors including nutrient availability, exopolysaccha-
ride production, oxygen availability, and other factors; thus,
this area requires substantial further expert investigation using
highly controlled culture environments. Moreover, S. iniae is a
highly diverse species (14, 23), and variability in growth char-
acteristics should be expected. However, our preliminary ex-
periments suggest that the type 2 enzyme may provide a
competitive advantage under conditions where the lactate con-
centration is high. Intriguingly, the farm from which the variant
was isolated is unusual as it is a marine farm with extremely
high tidal flow (8 to 9 meters). This results in currents in excess
of 3 knots through the anchored stainless steel cages, forcing
the fish to swim periodically in bursts to prevent collision with
the cage. During exercise, lactate is produced in the white
muscle tissue, which comprises around 65% of the total mus-
cle, of teleost fish (7, 31). The fate of muscle lactate and the
rate at which it is shuttled into plasma in teleosts are species
dependent (31, 32). While lactate metabolism has not been
FIG. 8. Protein structure of lactate oxidase in A. viridans and pre-
dicted protein structure models of type 1 and type 2 lactate oxidases in S.
iniae visualized in PyMOL. (A) Partial crystal structure of A. viridans
(PDB entry 2DU2) showing interactions between subunits 2 (yellow) and
3 (green). (B) Predicted model of type 1 lactate oxidase in S. iniae (based
on PDB entry 2J6X). (C) Predicted model of type 2 lactate oxidase in S.
iniae (based on PDB entry 2DU2). Green and yellow denote two separate
subunits. Blue sticks show determined (A) or predicted (B and C) active
sites for substrate. Light blue sticks show suggested (A) and predicted (B
and C) amino acids from a neighboring subunit participating in the en-
zymatic reaction at the active site. Red sticks show predicted positions of
inserted amino acids in S. iniae type 2 lactate oxidase variants.
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studied in barramundi, it is a strike predator that will undergo
periods of burst swimming likely to result in plasma lactate
accumulation similar to that reported for the silver trevally
(Pseudocarnax dentex) (32), in which plasma lactate levels in
excess of 21 mM were reported; this level is reported to be
inhibitory to S. iniae growth in brain heart infusion broth (11)
and reduced the growth rate of the type 1 enzyme-containing
strain in this study. The strains isolated from this site are the
only ones to date that have a type 2 lctO gene from an inter-
national collection of more than 100 strains from geographi-
cally disparate locations and hosts. Moreover, our earliest iso-
late from this site (QMA0109) isolated in April 2005 expresses
the type 2 enzyme, and the type 2 enzyme has been maintained
throughout subsequent outbreaks of disease. Intriguingly, un-
published work conducted in our laboratory has indicated that
later strains isolated from this site following vaccination in July
2005 (QMA0126 and all other 2006 isolates from the farm)
have substantial coding mutations in the capsular operon, re-
sulting in a serotype switch. In spite of these changes, perhaps
selected by vaccination, the type 2 lactate oxidase gene has
been maintained. Since these isolates from the Northern Ter-
ritory are able to process lactate at a faster rate than normal
lctO type 1 strains, it is tantalizing to hypothesize that environ-
mental influences of large tidal flows linked with increased
swimming activity have led to the evolution and retention of
the larger lctO gene encoding a more efficient enzyme in these
isolates of S. iniae.
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